MEDICAID: Provides relative to medicaid coverage of chimeric antigen receptor T-cell therapy (EN SEE FISC NOTE GF EX See Note)
Bill status
signed
all 5 stages cleared
Introduction
Mar 2023
Committee Review
May 2023
House Passage
Jun 2023
Senate Passage
Jun 2023
Signed into Law
Jun 2023
Introduced Mar 30, 2023
Signed Jun 12, 2023
Floor votes · Senate Jun 4, 2023 · House May 3, 2023
How they voted
31–0
Passed · 1 other
Total votes 32
Jun 4, 2023
D
Democratic10
100% Yea
R
Republican22
95% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
22
Key actions
5
Committee
5
Jun 6, 2023
Lower · Passed
Read by title, roll called, yeas 100, nays 0, Senate amendments concurred in.
lower
Jun 4, 2023
Upper · Passed
Rules suspended. Senate floor amendments read and adopted. Read by title, passed by a vote of 37 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.
upper
May 11, 2023
Committee
Read by title and referred to the Legislative Bureau.
upper
May 10, 2023
Upper · Passed
Reported favorably.
upper
May 3, 2023
Lower · Passed
Read third time by title, roll called on final passage, yeas 100, nays 1. Finally passed, title adopted, ordered to the Senate.
lower
Apr 25, 2023
Lower · Passed
Reported favorably (12-0).
lower
Apr 10, 2023
Committee
Read by title, under the rules, referred to the Committee on Health and Welfare.
lower
Mar 30, 2023
Committee
Under the rules, provisionally referred to the Committee on Health and Welfare.
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Aimee Freeman
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 435
Scope: LA
Hi! I can help you understand HB 435. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline